Each year, 500 to 1,000 people in the United States are diagnosed with pulmonary arterial hypertension (PAH). Because this progressive, chronic disorder is rare, it is often under-detected, causing ...

The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of ...

Winrevair, also known as sotatercept-csrk, is a medicine used to treat pulmonary arterial hypertension (PAH), which causes high blood pressure in the arteries that go from your heart to your lungs.

Just a year ago, walking 100 steps, much less 100 miles, was an impossible task for Davidson County resident Diane Ramirez.

Supervised pulmonary rehabilitation exercises help severe PAH lung transplant candidates maintain or improve exercise ...

Companies that manufacture diagnostics, technology and equipment to address the world’s most pressing medical issues have ...

Regulating drug discovery and pharmaceutical manufacturing, the FDA ensures the safety and effectiveness of innovative ...

The following is a summary of “Arterial stiffness measured by pulse wave velocity correlated with cognitive decline in ...

Two Indiana University doctors have been awarded grants by the American Lung Association Research Institute for their ...

Chronic Pulmonary Hypertension Treatment Market. The global chronic pulmonary hypertension treatment market is expected to ...

J.P. Morgan analyst Jessica Fye has maintained their bullish stance on UTHR stock, giving a Buy rating on October 25. Jessica Fye’s ...

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter ended September 30 ...